Inhibitory effects of tilianin on the expression of inducible nitric oxide synthase in low density lipoprotein receptor deficiency mice

Exp Mol Med. 2006 Aug 31;38(4):445-52. doi: 10.1038/emm.2006.52.

Abstract

We investigated the effect of tilianin upon inducible nitric oxide synthesis in the plasma of low-density lipoprotein receptor knock-out (Ldlr-/-) mice fed with high cholesterol diet and in primary peritoneal macrophages of Ldlr-/- mice. High cholesterol diet induced nitric oxide production in the plasma of Ldlr-/- mice. Tilianin reduced the level of nitric oxide (NO) in plasma from Ldlr-/- mice induced by the high cholesterol diet. Tilianin also inhibited the NO production from the primary culture of peritoneal macrophages treated with lipopolysaccharide. The inhibition of NO production was caused by the suppression of inducible nitric oxide synthase (iNOS) gene expression in peritoneal macrophages isolated from Ldlr-/- mice. Moreover, tilianin inhibited the transcriptional activation of iNOS promoter that has NF-kappaB binding element. Thus, these results provide the first evidence that tilianin inhibit iNOS expression and production of NO and may act as a potential anti-inflammatory agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / metabolism
  • Down-Regulation / drug effects
  • Flavonoids / pharmacology*
  • Glycosides / pharmacology*
  • Inflammation / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • NF-kappa B / metabolism
  • Nitric Oxide / biosynthesis
  • Nitric Oxide / blood
  • Nitric Oxide Synthase Type II / metabolism*
  • Promoter Regions, Genetic / drug effects
  • Receptors, LDL / genetics*
  • Sinus of Valsalva / metabolism
  • Sinus of Valsalva / pathology
  • Sinus of Valsalva / ultrastructure
  • Tissue Distribution
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism

Substances

  • Flavonoids
  • Glycosides
  • NF-kappa B
  • Receptors, LDL
  • tilianin
  • Nitric Oxide
  • 3-nitrotyrosine
  • Tyrosine
  • Nitric Oxide Synthase Type II